The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
EANO guidelines for the diagnosis and treatment of ependymal tumors
Open accessAbstract
Ependymal tumors are rare CNS tumors and may occur at any age, but their proportion among primary brain tumors is highest in children and young adults. Thus, the level of evidence of diagnostic and therapeutic interventions is higher in the pediatric compared with the adult patient population.The diagnosis and disease staging is performed by craniospinal MRI. Tumor classification is achieved by histological and molecular diagnostic assessment of tissue specimens according to the World Health Organization (WHO) classification 2016. Surgery is the crucial initial treatment in both children and adults. In pediatric patients with intracranial ependymomas of WHO grades II or III, surgery is followed by local radiotherapy regardless of residual tumor volume. In adults, radiotherapy is employed in patients with anaplastic ependymoma WHO grade III, and in case of incomplete resection of WHO grade II ependymoma. Chemotherapy alone is reserved for young children <12 months and for adults with recurrent disease when further surgery and irradiation are no longer feasible. A gross total resection is the mainstay of treatment in spinal ependymomas, and radiotherapy is reserved for incompletely resected tumors. Nine subgroups of ependymal tumors across different anatomical compartments (supratentorial, posterior fossa, spinal) and patient ages have been identified with distinct genetic and epigenetic alterations, and with distinct outcomes. These findings may lead to more precise diagnostic and prognostic assessments, molecular subgroup-adapted therapies, and eventually new recommendations pending validation in prospective studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Self-citationThe 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Pajtler, K. W., Witt, H., Sill, M., Jones, D. T. W., Hovestadt, V., Kratochwil, F., Wani, K., Tatevossian, R., Punchihewa, C., Johann, P., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.002 · Cited by 1,225
Self-citationOstrom, Q. T., Gittleman, H., Xu, J., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now207 · Cited by 1,204
C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma
Parker, M., Mohankumar, K. M., Punchihewa, C., Weinlich, R., Dalton, J. D., Li, Y., Lee, R., Tatevossian, R. G., Phoenix, T. N., Thiruvenkatam, R., et al. (2014) · Nature · doi:10.1038/nature13109 · Cited by 670
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Witt, H., Mack, S. C., Ryzhova, M., Bender, S., Sill, M., Isserlin, R., Benner, A., Hielscher, T., Milde, T., Remke, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.007 · Cited by 559
Self-citationConformal radiotherapy after surgery for paediatric ependymoma: a prospective study
Merchant, T. E., Li, C., Xiong, X., Kun, L. E., Boop, F. A., & Sanford, R. A. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70342-5 · Cited by 510
Brainin, M., Barnes, M., Baron, J. ‐., Gilhus, N. E., Hughes, R., Selmaj, K., & Waldemar, G. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00867.x · Cited by 375
Pajtler, K. W., Mack, S. C., Ramaswamy, V., Smith, C. A., Witt, H., Smith, A., Hansford, J. R., von Hoff, K., Wright, K. D., Hwang, E., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1643-0 · Cited by 337
Self-citationEllison, D. W., Kocak, M., Figarella-Branger, D., Felice, G., Catherine, G., Pietsch, T., Frappaz, D., Massimino, M., Grill, J., Boyett, J. M., et al. (2011) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-10-7 · Cited by 308
Self-citationLeone, M. A., Brainin, M., Boon, P., Pugliatti, M., Keindl, M., & Bassetti, C. L. (2013) · European Journal of Neurology · doi:10.1111/ene.12043 · Cited by 280
Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy
Indelicato, D. J., Flampouri, S., Rotondo, R. L., Bradley, J. A., Morris, C. G., Aldana, P. R., Sandler, E., & Mendenhall, N. P. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.957414 · Cited by 212
Ramaswamy, V., Hielscher, T., Mack, S. C., Lassaletta, A., Lin, T., Pajtler, K. W., Jones, D. T. W., Luu, B., Cavalli, F. M. G., Aldape, K., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.7825 · Cited by 206
Self-citationGururangan, S., Chi, S. N., Young Poussaint, T., Onar-Thomas, A., Gilbertson, R. J., Vajapeyam, S., Friedman, H. S., Packer, R. J., Rood, B. N., Boyett, J. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8789 · Cited by 194
Bayliss, J., Mukherjee, P., Lu, C., Jain, S. U., Chung, C., Martinez, D., Sabari, B., Margol, A. S., Panwalkar, P., Parolia, A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6904 · Cited by 191
Intramedullary spinal cord tumors: a review of current and future treatment strategies
Tobin, M. K., Geraghty, J. R., Engelhard, H. H., Linninger, A. A., & Mehta, A. I. (2015) · Neurosurgical Focus · doi:10.3171/2015.5.focus15158 · Cited by 189
Biology and management of ependymomas
Wu, J., Armstrong, T. S., & Gilbert, M. R. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now016 · Cited by 189
C11ORF95-RELA FUSIONS DRIVE ONCOGENIC NF-KB SIGNALING IN EPENDYMOMA
Gilbertson, R., Parker, M., Mohankumar, K. M., Punchihewa, C., Weinlich, R., Dalton, J. D., Li, Y., Lee, R., Tatevossian, R. G., Phoenix, T. N., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou206.57 · Cited by 173
A prognostic gene expression signature in infratentorial ependymoma
For the Collaborative Ependymoma Research Network, Wani, K., Armstrong, T. S., Vera-Bolanos, E., Raghunathan, A., Ellison, D., Gilbertson, R., Vaillant, B., Goldman, S., Packer, R. J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0941-4 · Cited by 162
Self-citationRobison, N. J., Campigotto, F., Chi, S. N., Manley, P. E., Turner, C. D., Zimmerman, M. A., Chordas, C. A., Werger, A. M., Allen, J. C., Goldman, S., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24794 · Cited by 151
MacDonald, S. M., Sethi, R., Lavally, B. L., Yeap, B. Y., Marcus, K. J., Caruso, P. A., Pulsifer, M., Huang, M., Ebb, D. H., Tarbell, N. J., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not121 · Cited by 150
Merchant, T. E., Kiehna, E. N., Li, C., Xiong, X., & Mulhern, R. K. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.05.028 · Cited by 148
Kilday, J., Mitra, B., Domerg, C., Ward, J. H., Andreiuolo, F. D. M., Osteso-Ibáñez, T., Mauguen, A., Varlet, P., Deley, M. L., Lowe, J. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2489 · Cited by 141
Survival Benefit for Pediatric Patients With Recurrent Ependymoma Treated With Reirradiation
Bouffet, É., Hawkins, C. E., Ballourah, W., Taylor, M. D., Bartels, U. K., Schoenhoff, N. J., Tsangaris, E., Huang, A., Kulkarni, A. V., Mabbott, D., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.10.039 · Cited by 140
Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma
Massimino, M., Miceli, R., Giangaspero, F., Boschetti, L., Modena, P., Antonelli, M., Ferroli, P., Bertin, D., Pecori, E., Valentini, L. G., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now108 · Cited by 136
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
Vera‐Bolanos, E., Aldape, K., Yuan, Y., Wu, J., Wani, K., Necesito-Reyes, M. J., Colman, H., Dhall, G., Lieberman, F. S., Métellus, P., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou162 · Cited by 132
Self-citationProton Therapy in Children: A Systematic Review of Clinical Effectiveness in 15 Pediatric Cancers
Leroy, R., Benahmed, N., Hulstaert, F., Damme, N. V., & Ruysscher, D. D. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.10.025 · Cited by 128
Pietsch, T., Wohlers, I., Goschzik, T., Dreschmann, V., Denkhaus, D., Dörner, E., Rahmann, S., & Klein‐Hitpaß, L. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1264-4 · Cited by 125
Garvin, J. H., Selch, M. T., Holmes, E., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24274 · Cited by 123
Chemotherapy for intracranial ependymomas
Bouffet, É., & Foreman, N. K. (1999) · Child s Nervous System · doi:10.1007/s003810050544 · Cited by 120
Is gross-total resection sufficient treatment for posterior fossa ependymomas?
Rogers, L., Pueschel, J. K., Spetzler, R., Shapiro, W., Coons, S. W., Thomas, T., & Speiser, B. L. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.102.4.0629 · Cited by 118
Adult ependymal tumors: prognosis and the M. D. Anderson Cancer Center experience
Armstrong, T. S., Vera‐Bolanos, E., Bekele, B. N., Aldape, K. D., & Gilbert, M. R. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq009 · Cited by 115
Radiotherapeutic management of adult intraspinal ependymomas
Shaw, E. G., Evans, R. G., Scheithauer, B. W., Ilstrup, D. M., & Earle, J. D. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90345-7 · Cited by 113
Massimino, M., Gandola, L., Giangaspero, F., Sandri, A., Valagussa, P., Perilongo, G., Garrè, M. L., Ricardi, U., Forni, M., Genitori, L., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.08.030 · Cited by 107
Ependymomas of the adult: molecular biology and treatment
Rudà, R., Gilbert, M. R., & Soffietti, R. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328317efe8 · Cited by 95
Self-citationBrandes, A. A., Cavallo, G., Reni, M., Tosoni, A., Nicolardi, L., Scopece, L., Franceschi, E., Sotti, G., Talacchi, A., Turazzi, S., et al. (2005) · Cancer · doi:10.1002/cncr.21110 · Cited by 90
Current therapy and the evolving molecular landscape of paediatric ependymoma
Khatua, S., Ramaswamy, V., & Bouffet, É. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.10.013 · Cited by 80
Bevacizumab for recurrent ependymoma
Green, R. M., Cloughesy, T. F., Stupp, R., DeAngelis, L. M., Woyshner, E., Ney, D. E., & Lassman, A. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c1df34 · Cited by 78
Long-term quality of life in children treated for posterior fossa brain tumors: Clinical article
Kulkarni, A. V., Piscione, J., Shams, I., & Bouffet, É. (2013) · Journal of Neurosurgery Pediatrics · doi:10.3171/2013.6.peds12535 · Cited by 75
DeWire, M. D., Fouladi, M., Turner, D. C., Wetmore, C., Hawkins, C. E., Jacob, C., Yuan, Y., Liu, D., Goldman, S., Fisher, P. G., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1764-7 · Cited by 67
Good, C. D., Wade, A. M., Hayward, R. D., Phipps, K. P., Michalski, A. J., Harkness, W. F. J., & Chong, W. K. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.94.1.0027 · Cited by 66
Chemotherapy for Advanced CNS Ependymoma
Gornet, M., Buckner, J. C., Marks, R. S., Scheithauer, B. W., & Erickson, B. J. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006394407245 · Cited by 63
Myxopapillary ependymomas in children: imaging, treatment and outcomes
Bandopadhayay, P., Silvera, V. M., Ciarlini, P. D. S. C., Malkin, H., Bi, W. L., Bergthold, G., Faisal, A. M., Ullrich, N. J., Marcus, K. J., Scott, R. M., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1955-2 · Cited by 60
Rudà, R., Bosa, C., Magistrello, M., Franchino, F., Pellerino, A., Fiano, V., Trevisan, M., Cassoni, P., & Soffietti, R. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov167 · Cited by 57
Self-citationTemozolomide for recurrent intracranial supratentorial platinum‐refractory ependymoma
Chamberlain, M. C., & Johnston, S. K. (2009) · Cancer · doi:10.1002/cncr.24524 · Cited by 53
Etoposide for recurrent spinal cord ependymoma
Chamberlain, M. C. (2002) · Neurology · doi:10.1212/wnl.58.8.1310 · Cited by 49
Radiosurgery for Pediatric Brain Tumors
Murphy, E. S., Chao, S. T., Angelov, L., Vogelbaum, M. A., Barnett, G. H., Jung, E., Recinos, V. R., Mohammadi, A. M., & Suh, J. H. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25831 · Cited by 45
Hollon, T. C., Nguyen, V., Smith, B. W., Lewis, S., Junck, L., & Orringer, D. A. (2016) · Journal of neurosurgery · doi:10.3171/2015.7.jns151187 · Cited by 45
Brainin, M., Barnes, M., Baron, J., Ne, G., Hughes, R. A., Selmaj, K. W., & Waldemar, G. (2011) · Wiley eBooks · doi:10.1002/9781444346268.ch1 · Cited by 38
Jakacki, R. I., Foley, M. A., Horan, J. D., et al. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2155-4 · Cited by 30
Dorfer, C., Tonn, J. C., & Rutka, J. T. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802997-8.00025-6 · Cited by 29
Self-citationTreatment and survival of supratentorial and posterior fossa ependymomas in adults
Nuño, M., Yu, J. J., Varshneya, K., Alexander, J. E., Mukherjee, D. R., Black, K. L., & Patil, C. G. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.11.014 · Cited by 24
Cited by
Primary brain tumours in adults
Lapointe, S., Perry, A., & Butowski, N. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30990-5 · Cited by 1,366
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review
Schaff, L. R., & Mellinghoff, I. K. (2023) · JAMA · doi:10.1001/jama.2023.0023 · Cited by 1,271
Weller, M., Wen, P. Y., Chang, S. M., Dirven, L., Lim, M., Monje, M., & Reifenberger, G. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00516-y · Cited by 592
Self-citationPrimary brain tumours in adults
van den Bent, M. J., Geurts, M., French, P. J., Smits, M., Capper, D., Bromberg, J. E. C., & Chang, S. M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01054-1 · Cited by 419
Horbinski, C., Berger, T., Packer, R. J., & Wen, P. Y. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00679-w · Cited by 312
Metadata
- Authors
- Rudà, R., Reifenberger, G., Frappaz, D., Pfister, S. M., Laprie, A., Santarius, T., Roth, P., Tonn, J. C., Soffietti, R., Weller, M., & Moyal, E. C.-J.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-11-29
- Volume
- 20
- Issue
- 4
- Pages
- 445-456
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2768707078
- Cited by
- 299
- References
- 53
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.